Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $12.65 billion. The enterprise value is $23.92 billion.
| Market Cap | 12.65B |
| Enterprise Value | 23.92B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025, before market open.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 95.12 million shares outstanding. The number of shares has decreased by -6.60% in one year.
| Current Share Class | 95.12M |
| Shares Outstanding | 95.12M |
| Shares Change (YoY) | -6.60% |
| Shares Change (QoQ) | -0.80% |
| Owned by Insiders (%) | 1.20% |
| Owned by Institutions (%) | 96.38% |
| Float | 93.88M |
Valuation Ratios
The trailing PE ratio is 4.07 and the forward PE ratio is 11.01. THC's PEG ratio is 1.05.
| PE Ratio | 4.07 |
| Forward PE | 11.01 |
| PS Ratio | 0.62 |
| Forward PS | 0.60 |
| PB Ratio | 3.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.35 |
| P/OCF Ratio | 6.19 |
| PEG Ratio | 1.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.93, with an EV/FCF ratio of 21.44.
| EV / Earnings | 7.48 |
| EV / Sales | 1.16 |
| EV / EBITDA | 5.93 |
| EV / EBIT | 7.43 |
| EV / FCF | 21.44 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 1.68.
| Current Ratio | 1.78 |
| Quick Ratio | 1.54 |
| Debt / Equity | 1.68 |
| Debt / EBITDA | 3.22 |
| Debt / FCF | 12.84 |
| Interest Coverage | 3.90 |
Financial Efficiency
Return on equity (ROE) is 57.83% and return on invested capital (ROIC) is 9.02%.
| Return on Equity (ROE) | 57.83% |
| Return on Assets (ROA) | 7.03% |
| Return on Invested Capital (ROIC) | 9.02% |
| Return on Capital Employed (ROCE) | 13.07% |
| Revenue Per Employee | $210,867 |
| Profits Per Employee | $32,653 |
| Employee Count | 98,000 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 32.91 |
Taxes
In the past 12 months, THC has paid $1.18 billion in taxes.
| Income Tax | 1.18B |
| Effective Tax Rate | 22.56% |
Stock Price Statistics
The stock price has increased by +26.96% in the last 52 weeks. The beta is 2.07, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 2.07 |
| 52-Week Price Change | +26.96% |
| 50-Day Moving Average | 132.39 |
| 200-Day Moving Average | 143.69 |
| Relative Strength Index (RSI) | 55.72 |
| Average Volume (20 Days) | 1,687,452 |
Short Selling Information
The latest short interest is 3.87 million, so 4.07% of the outstanding shares have been sold short.
| Short Interest | 3.87M |
| Short Previous Month | 3.42M |
| Short % of Shares Out | 4.07% |
| Short % of Float | 4.12% |
| Short Ratio (days to cover) | 2.22 |
Income Statement
In the last 12 months, THC had revenue of $20.67 billion and earned $3.20 billion in profits. Earnings per share was $32.70.
| Revenue | 20.67B |
| Gross Profit | 8.21B |
| Operating Income | 3.22B |
| Pretax Income | 3.76B |
| Net Income | 3.20B |
| EBITDA | 4.04B |
| EBIT | 3.22B |
| Earnings Per Share (EPS) | $32.70 |
Balance Sheet
The company has $3.02 billion in cash and $14.33 billion in debt, giving a net cash position of -$11.26 billion or -$118.35 per share.
| Cash & Cash Equivalents | 3.02B |
| Total Debt | 14.33B |
| Net Cash | -11.26B |
| Net Cash Per Share | -$118.35 |
| Equity (Book Value) | 8.55B |
| Book Value Per Share | 43.85 |
| Working Capital | 3.37B |
Cash Flow
In the last 12 months, operating cash flow was $2.05 billion and capital expenditures -$931.00 million, giving a free cash flow of $1.12 billion.
| Operating Cash Flow | 2.05B |
| Capital Expenditures | -931.00M |
| Free Cash Flow | 1.12B |
| FCF Per Share | $11.73 |
Margins
Gross margin is 39.72%, with operating and profit margins of 15.57% and 15.49%.
| Gross Margin | 39.72% |
| Operating Margin | 15.57% |
| Pretax Margin | 25.40% |
| Profit Margin | 15.49% |
| EBITDA Margin | 19.53% |
| EBIT Margin | 15.57% |
| FCF Margin | 5.40% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.60% |
| Shareholder Yield | n/a |
| Earnings Yield | 25.27% |
| FCF Yield | 8.81% |
Analyst Forecast
The average price target for THC is $164.00, which is 23.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $164.00 |
| Price Target Difference | 23.32% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 4.16% |
| EPS Growth Forecast (5Y) | -2.47% |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 0.25:1.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.25:1 |
Scores
THC has an Altman Z-Score of 1.73 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.73 |
| Piotroski F-Score | 6 |